15-51243944-T-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000103.4(CYP19A1):c.-38-994A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.494 in 151,996 control chromosomes in the GnomAD database, including 19,168 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.49   (  19168   hom.,  cov: 32) 
Consequence
 CYP19A1
NM_000103.4 intron
NM_000103.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.503  
Publications
42 publications found 
Genes affected
 CYP19A1  (HGNC:2594):  (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74). 
BP6
Variant 15-51243944-T-G is Benign according to our data. Variant chr15-51243944-T-G is described in ClinVar as Benign. ClinVar VariationId is 1170825.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.56  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CYP19A1 | NM_000103.4  | c.-38-994A>C | intron_variant | Intron 1 of 9 | ENST00000396402.6 | NP_000094.2 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.494  AC: 75024AN: 151878Hom.:  19166  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
75024
AN: 
151878
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.494  AC: 75053AN: 151996Hom.:  19168  Cov.: 32 AF XY:  0.494  AC XY: 36720AN XY: 74300 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
75053
AN: 
151996
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
36720
AN XY: 
74300
show subpopulations 
African (AFR) 
 AF: 
AC: 
14628
AN: 
41444
American (AMR) 
 AF: 
AC: 
7789
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1987
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2188
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
2375
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
6002
AN: 
10578
Middle Eastern (MID) 
 AF: 
AC: 
127
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
38385
AN: 
67938
Other (OTH) 
 AF: 
AC: 
1036
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1940 
 3879 
 5819 
 7758 
 9698 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 672 
 1344 
 2016 
 2688 
 3360 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1310
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Nov 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.